A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Cutaneous melanoma (CM) is a life-threatening form of skin cancer. Prognostic biomarkers can reliably stratify patients at initial melanoma diagnosis according to risk, and may inform clinical decisions. Here, we performed a retrospective, cohort-based study analyzing genome-wide DNA methylation of...
Main Authors: | Wenna Guo, Liucun Zhu, Rui Zhu, Qihan Chen, Qiang Wang, Jian-Qun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-06-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/44310 |
Similar Items
-
Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
by: Wenna Guo, et al.
Published: (2022-12-01) -
Construction and validation of a novel prognostic signature for cutaneous melanoma based on ferroptosis-related genes
by: Wenna Guo, et al.
Published: (2023-05-01) -
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
by: Damian J. Ralser, et al.
Published: (2023-06-01) -
Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
by: Vasiliki Nikolaou, et al.
Published: (2023-03-01) -
Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma
by: Ruihuan Shen, et al.
Published: (2023-06-01)